NCT01535157 2020-08-27
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
South Plains Oncology Consortium
Phase 1/2 Terminated
South Plains Oncology Consortium
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Janssen Research & Development, LLC